1.1 Articolo in rivista: [26879] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.841 a 7.860 di 26.879
Titolo Data di pubblicazione Autore(i) File
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma 1-gen-2020 Colombo, N; Oza, Am; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Weberpals, Ji; Clamp, Ar; Scambia, G; Leary, A; Holloway, Rw; Gancedo Margarita, A; Fong, Pc; Goh, Jc; O'Malley, Dm; Armstrong, Dk; Banerjee, S; García-Donas, J; Swisher, Em; Meunier, J; Cameron, T; Maloney, L; Goble, S; Bedel, J; Ledermann, Ja; Coleman, Rl
Potential impact of introducing a nonavalent HPV vaccination 1-gen-2018 Bogani, G; Taverna, F; Lombardo, C; Signorelli, M; Chiappa, V; Casarin, J; Scaffa, C; Leone Roberti Maggiore, U; Recalcati, D; Ditto, A; Martinelli, F; Borghi, C; Perotto, S; Ferrero, S; Lorusso, D; Raspagliesi, F
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study 1-gen-2015 Konecny, Ge; Finkler, N; Garcia, Aa; Lorusso, D; Lee, Ps; Rocconi, Rp; Fong, Pc; Squires, M; Mishra, K; Upalawanna, A; Wang, Yy; Kristeleit, R
The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer 1-gen-2017 Lorusso, D; Fontanella, C; Maltese, G; Lepori, S; Tripodi, E; Bogani, G; Raspagliesi, F.
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 1-gen-2016 Perrone, F; Baldassarre, G; Indraccolo, S; Signoriello, S; Chiappetta, G; Esposito, F; Ferrandina, G; Franco, R; Mezzanzanica, D; Sonego, M; Zulato, E; Zannoni, Gf; Canzonieri, V; Scambia, G; Sorio, R; Savarese, A; Breda, E; Scollo, P; Ferro, A; Tamberi, S; Febbraro, A; Natale, D; Di Maio, M; Califano, D; Scognamiglio, G; Lorusso, D; Canevari, S; Losito, S; Gallo, C; Pignata, S
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy 1-gen-2011 Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.; Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.
Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures 1-gen-2015 Ditto, A; Martinelli, F; Bogani, G; Lorusso, D; Carcangiu, M; Chiappa, V; Reato, C; Donfrancesco, C; De Carrillo, Kja; Raspagliesi, F
Advanced vulvar carcinoma: Is it worth operating? A perioperative management protocol for radical and reconstructive surgery 1-gen-2006 Fanfani, Francesco; Garganese, Giorgia; Fagotti, Anna; Lorusso, D; Gagliardi Maria, Lucia; Rossi, Marco; Salgarello, Marzia; Scambia, Giovanni
Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer 1-gen-2022 Lorusso, D; Guy, H; Samyshkin, Y; Hawkes, C; Estenson, K; Coleman, Rl; Lorusso, D; Guy, H; Samyshkin, Y; Hawkes, C; Estenson, K; Coleman, Rl
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives 1-gen-2021 Maiorano, Ba; Maiorano, Mfp; Lorusso, D; Maiello, E
Treatment of Recurrent Endometrial Carcinoma: Progress Toward a More Personalized Approach 1-gen-2015 Bogani, G; Chiappa, V; Lorusso, D; Raspagliesi, F
Phase II Study of NGR-hTNF Plus Doxorubicin in Relapsed Ovarian Cancer (OC) 1-gen-2011 Lorusso, D; Scambia, G.; Amadio, G.; Trivellizzi, N.; Pietragalla, A.; De Vincenzo, R.; Salutari, V.; Di Stefano, M.; Lambiase, A.; Bordignon, C.
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer 1-gen-2016 Mirza, Mr; Monk, Bj; Herrstedt, J; Oza, Am; Mahner, S; Redondo, A; Fabbro, M; Ledermann, Ja; Lorusso, D; Et, Al.
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 1-gen-2020 Brewer, M; Angioli, R; Scambia, G; Lorusso, D; Terranova, C; Benedetti Panici, P; Raspagliesi, F; Scollo, P; Plotti, F; Ferrandina, G; Salutari, V; Ricci, C; Braly, P; Holloway, R; Method, M; Madiyalakan, M; Bayever, E; Nicodemus, C; Brewer, M; Angioli, R; Scambia, G; Lorusso, D; Terranova, C; Benedetti Panici, P; Raspagliesi, F; Scollo, P; Plotti, F; Ferrandina, G; Salutari, V; Ricci, C; Braly, P; Holloway, R; Method, M; Madiyalakan, M; Bayever, E; Nicodemus, C
Incorporating 3D laparoscopy for the management of locally advanced cervical cancer: a comparison with open surgery 1-gen-2016 Raspagliesi, F; Bogani, G; Martinelli, F; Signorelli, M; Chiappa, V; Scaffa, C; Sabatucci, I; Adorni, M; Lorusso, D; Ditto, A
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Squamous Cell Carcinoma of the Ovary 1-gen-2014 Glasspool, Rm; Martin, Ag; Millan, D; Lorusso, D; Avall-Lundqvist, E; Hurteau, Ja; Davis, A; Hilpert, F; Kim, Jw; Alexandre, J; Ledermann, Ja
Quality of life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 1-gen-2018 Piccirillo, Mc; Scambia, G; Bologna, A; Signoriello, S; Vergote, I; Baumann, K; Lorusso, D; Murgia, V; Sorio, R; Ferrandina, G; Sacco, C; Cormio, G; Breda, E; Cinieri S, ; Natale, D; Mangili, G; Pisano, C; Cecere, Sc; Di Napoli, M; Salutari, V; Raspagliesi F, ; Arenare, L; Bergamini, A; Bryce, J; Daniele, G; Gallo, C; Pignata, S; Perrone, F.
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer 1-gen-2003 D'Agostino, G; Ferrandina, G; Ludovisi, M; Testa, A; Lorusso, D; Gbaguidi, N; Breda, E; Mancuso, S; Scambia, G
Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study 1-gen-2011 Marchetti, Claudia; Pisano, Carmela; Mangili, Giorgia; Lorusso, D; Panici Pierluigi, Benedetti; Silvestro, Giustino; Candiani, Massimo; Greggi, Stefano; Perniola, Giorgia; Di Maio, Massimo; Pignata, Sandro
[Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.] 1-gen-2021 Danesi, R.; Cremolini, C.; Ciccarone, F.; Lorusso, D.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.841 a 7.860 di 26.879
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista26879
Autore
  • OYEN, Willem Jozef Gerard891
  • SANTORO, Armando806
  • CANONICA, Giorgio775
  • REPICI, Alessandro723
  • HASSAN, CESARE690
  • DANESE, Silvio643
  • FASANO, ALFONSO471
  • Marcacci, Maurilio467
  • D'INCALCI, MAURIZIO466
  • LAGHI, ANDREA456
Data di pubblicazione
  • In corso di stampa6
  • 2020 - 20269083
  • 2010 - 201911532
  • 2000 - 20094500
  • 1990 - 19991429
  • 1980 - 1989306
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE368
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
  • ANNALS OF ONCOLOGY243
  • CANCERS227
  • THE JOURNAL OF NUCLEAR MEDICINE220
  • PLOS ONE212
  • EUROPEAN JOURNAL OF CANCER205
  • GASTROINTESTINAL ENDOSCOPY193
  • JOURNAL OF CLINICAL MEDICINE182
  • ALLERGY180
Keyword
  • Humans2101
  • Female1005
  • Male964
  • Middle Aged745
  • Aged643
  • Adult550
  • COVID-19415
  • Treatment Outcome359
  • Animals321
  • Retrospective Studies262
Lingua
  • eng19160
  • ita408
  • spa13
  • fre11
  • ger8
  • enm3
  • por2
  • chi1
Accesso al fulltext
  • no fulltext24626
  • reserved1362
  • open891